Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Vasodialators Erythromycin-microencapsulated-granules

 Methylation of de-A steroids
We claim: 1. In a process wherein a de A-steroid of the formula ##STR6## wherein R' is a ketalized 3...


 Antibiotic LL-E19085
OF THE INVENTION The antibacterial agents LL-E19085.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E...


 Amino-substituted imidazo[1,2-a:3,4-a']diquinolin-15-ium salts compositions and method of use
What is claimed is: 1. A compound having the formula I: ##STR45## wherein R.sub.1 is hydrogen, ...


 Process for producing benzonitrile
What is claimed is: 1. A process for producing benzonitrile comprising reacting toluene with ...


 Percutaneous absorption type pharmaceutical preparation of isosorbide dinitrate or pentaerythritol tetranitrate in pressure-sensitive laminate
OF THE INVENTION Polymers having a glass transition temperature (Tg) (measured using a ...


 Waterproof sunscreen compositions
What I claim is: 1. A water-proof sunscreen composition comprising: A. from about 15% to about 90% ...


 4-Hydroxy-2-benzimidazoline-thione compounds and pharmaceutical compositions containing them
What is claimed is: 1. 4-Hydroxy-2-benzimidazoline-thione compound of the formula ##STR8## wherein R...


 Insecticidal combinations
I claim: 1. An insecticidal composition containing as active ingredient a combination of (a) 3,4-...


 Method for the separation and recovery of furfural and organic volatile acids, such as acetic acid and formic acid, from the process of preparation of furfural
What I claim is: 1. A method for the separation and recovery of furfural and volatile organic acids ...


 1-Benzoyl-3-hydroxy-6(1H)-pyridazinones and use as plant growth regulators
We claim: 1. A compound having the structural formula ##STR5## in which Y is --COOH or an ...


 Erythromycin microencapsulated granules

Details
Inventors: Giannini, Robert P.; Fromm, Susan M.; Suarez, Jose;
Assignee: hiMedics, Inc. (Hollywood, FL)
Primary Examiner: Page; Thurman K.
Assistant Examiner:
Attorney, Agent or Firm: Venable, Baetjer, Howard & Civiletti

The invention disclosed is erythromycin microencapsulated granules activity densities greater than about 0.300 g/ml. These granules are unusually small having diameters less than about 1000 microns. The granules are particularly useful in hand-held flowable material dispensers. A process for manufacturing such granules is also disclosed.

DETAILED DESCRIPTION OF THE INVENTION The invention relates to pharmaceutically active microencapsulated granules comprising erythromycin and a binder.
Such erythromycin granules are particularly useful in flowable material dispensing devices.
One such dispensing device is the "Flowable Material Dispenser" disclosed in U.
S.
Pat.
No.
4,579,256 incorporated herein by reference.
In order for pharmaceutically active granules to be used in the above-described dispenser, such granules must exhibit a high concentration of pharmaceutically active agent, a small size, a narrow size distribution and a uniformity of shape, preferably spherical.
They must also be resilient enough to withstand packaging on high speed filling equipment and shipment throughout the world.
The uniformly spherical granules ensure the accuracy and reproducibility of doses from the dispenser.
The properties of high concentration and small size are necessary for convenience of administration by minimizing the amount of granules the patient has to swallow.
The high concentration and small size, along with the narrow size distribution of uniformly spherical granules are also desirable so that the granules do not create an unpleasant gritty feeling in the patient's mouth when the granules are ingested with the food on which they are dispensed.
Small average size is also necessary if the flowable material dispenser is to be kept small enough to be hand-held and hand-operated.
The erythromycin granules which meet the above concentration, size and shape requirements comprise a starting seed which has an active coating applied thereto.
The active coating comprises erythromycin and a binder.
Erythromycin is a well-known antibiotic which is available as white or slightly yellow crystals or powder.
It is slightly hygroscopic and has a pK.
sub.
a of 8.
7.
Erythromycin is very slightly soluble in water, and freely soluble in alcohol, chloroform, ether and acetone, and moderately soluble in amyl acetate and ethylene dichloride.
Suitable binders for use with the erythromycin include hydroxypropyl methylcellulose phthalate, polyvinylpyrrolidone, hydroxypropyl methylcellulose, polyethylene glycol, hydroxylpropyl cellulose, polyethylene oxide, cellulose acetate phthalate, polyvinyl acetate phthalate and mixtures thereof



Related patents
  Pharmaceutical preparation
We claim: 1. Controlled release preparation comprising a plurality of beads having a soluble component comprising at least 95% weight/weight of a salt of metoprolol ...
  Mold apparatus having an outwardly angled seal for encapsulating a glass sheet
The present invention concerns an improved mold apparatus and method for at least partially encapsulating a sheet by forming a window assembly comprising a gasket and a ...
  4,5,6,7-Tetrahydro-thieno[3,2-c]-pyridine derivatives and process for their preparation
Having now described our invention what we claim as new and desire to secure by Letters Patent is: 1. A compound selected from the group consisting of 4,5,6,7-tetrahydro-...
  Process for dimerization, arylation and trifluoromethylation of aromatic and heterocyclic compounds
OF THE INVENTION It has been found in accordance with this invention that aromatic and heterocyclic compounds can be arylated and trifluoromethylated in a convenient ...
  Mercaptoacyldihydropyrazole carboxylic acid derivatives
OF THE INVENTION The compounds of formula I are useful as hypotensive agents. They inhibit the conversion of the decapeptide angiotensin I to angiotensin II and, ...
  Process for preparation 4,5,6,7-tetrahydro-7-oxobenzo-[b]-thiophenes and 1,2,3,4-tetrahydro-4-oxo-1-naphthalenes
I claim: 1. A process for the preparation of a compound of the formula: ##STR13## wherein R.sub.1 and R.sub.2 are each a substituent selected from the group consisting ...
  4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
About 70% of all renal calculi contain oxalate as the main component of the matrix. In the majority of patients the condition is associated with a higher than average ...
  Method for producing 1-nitroanthraquinone
What is claimed is: 1. A method for producing 1-nitroanthraquinone by nitration of anthraquinone, which comprises reacting anthraquinone at a temperature of 30.degree. ...
  N-pyrazinecarbonyl-N'-acylguanidines
What is claimed is: 1. A compound of the formula: ##STR3## wherein R.sup.1 is hydrogen or lower alkyl having 1 to 5 carbon atoms; R.sup.2 is methyl or halogen; R.sup.3 ...
  Novel analogs of prostaglandins with 4-oxo-thiazolidinyl nucleus and method of preparation thereof
What is claimed is: 1. The compound of the formula ##STR41## wherein R is carboxy, a carboxy salt, or derivatized carboxy; A is selected from the group consisting of ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved